Avacta : Preliminary Results for the year ended 31 December 2022

A period of continued significant progress



Avacta Group plc , a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to... | April 25, 2023

Related Keywords

United States ,New York ,London ,City Of ,United Kingdom ,Ireland ,Germany ,Florida ,Cambridge ,Cambridgeshire ,Glasgow ,Glasgow City ,France ,Sweden ,South Korea ,Manchester ,China ,American ,Chinese ,America ,South Korean ,Korea ,Mike Owen ,Alastair Smith ,Eliot Forster ,Genscript Probio ,Tony Gardiner ,Christina Coughlin ,Revenues For The Therapeutics Division ,American Association For Cancer Research ,Animal Health Division ,Group Diagnostics Division ,Cytoimmune Therapeutics Inc ,Bonds ,Fred Hutchinson Cancer Center ,Imperial College White City Campus ,Daewoong Pharmaceuticals ,Company Phase ,Therapeutics Division ,Rubius Therapeutics Inc ,Lg Chem Life Sciences ,Safety Data Monitoring Committee ,Diagnostics Division ,Regulatory Agency ,Korean Lg Group ,Group Diagnostics ,Tmunity Therapeutics Inc ,Drug Administration ,Whilst The Company ,Animal Health Division To Vimian Group ,Diagnostics Holdings Ltd Launch ,American Association For Cancer Research Annual Meeting ,Company Affimer ,American Cancer Society ,Avacta Animal Health ,Avacta Therapeutics Division ,Memorial Sloane Kettering Cancer Center ,Vimian Group ,Avacta Diagnostics Division ,Foundation Trust In Manchester ,Animal Health ,Affyxell Therapeutics Co Ltd ,Clinical Technology Solution Center ,Revenues For The Diagnostics Division ,Biopharma Inc ,Avacta Group ,Avacta Employee Share ,Registrar Of Companies ,Drug Development Collaborations ,Heights Capital Ireland ,American Association ,Cancer Research ,Orphan Drug Designation ,Investigational New Drug Application ,Xell Therapeutics ,Daewoong Pharmaceutical ,Korea Non Clinical Technology Solution Center ,Life Sciences ,Scale Space ,Imperial College ,White City Campus ,Science Day ,Launch Diagnostics ,Chief Executive Officer ,Cytoimmune Therapeutics ,Non Executive Director ,Cancer Research Annual ,Avacta Diagnostics ,Diagnostic Divisions ,Rubius Therapeutics ,Tmunity Therapeutics ,White City ,Scientific Advisory Board ,Royal Marsden ,Investigational New Drug ,Clinical Trial Authorisation ,Annual Meeting ,Host Disease ,Launch Diagnostics Holdings Ltd ,Launch Diagnostic ,Consolidated Statement ,Financial Position ,Alternative Performance Measures ,Year Ended ,Preliminary Results ,Companies Act ,Annual General ,Avacta Employee Share Trust ,Avacta Share Incentive Plan ,Avacta Group Plc Stock Exchange ,News ,Information ,Press Release , ,Eriod ,F ,Ontinued ,Significant ,Avacta ,Group ,Lc ,Life ,Ciences ,Company ,Developing ,Argeted ,Ncology ,Drugs ,End ,Powerful ,Us ,Leased Avct Gb00byyw9g87 ,